TY - JOUR
T1 - Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons
AU - Corenblum, M. J.
AU - McRobbie-Johnson, A.
AU - Carruth, E.
AU - Bernard, K.
AU - Luo, M.
AU - Mandarino, L. J.
AU - Peterson, S.
AU - Sans-Fuentes, M. A.
AU - Billheimer, D.
AU - Maley, T.
AU - Eggers, E. D.
AU - Madhavan, L.
N1 - Publisher Copyright: © 2023 The Authors
PY - 2023/10
Y1 - 2023/10
N2 - Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
AB - Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
KW - Aging
KW - Human Induced Pluripotent Stem Cells
KW - Midbrain Dopamine Neurons
KW - Mitochondrial Dysfunction
KW - Parkinson's disease
KW - Skin fibroblasts
UR - http://www.scopus.com/inward/record.url?scp=85165461561&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165461561&partnerID=8YFLogxK
U2 - 10.1016/j.pneurobio.2023.102501
DO - 10.1016/j.pneurobio.2023.102501
M3 - Article
C2 - 37451330
SN - 0301-0082
VL - 229
JO - Progress in Neurobiology
JF - Progress in Neurobiology
M1 - 102501
ER -